Fox Chase Cancer Center News

PHILADELPHIA (January 31, 2023)—Fox Chase Cancer Center has been awarded Gold Certification for Excellence in Person-Centered Care by Planetree International, which recognizes Fox Chase’s achievement and innovation in the delivery of person-centered care. Fox Chase is one of only 98 healthcare organizations worldwide to earn this prestigious award, and only one of four organizations that focus on cancer care to be honored.

PHILADELPHIA (January 23, 2023)—Fox Chase Cancer Center has achieved Magnet designation for nursing excellence from the American Nurses Credentialing Center (ANCC) for the sixth consecutive time. Fox Chase has held Magnet status continuously since 2000, when it became the first hospital in Pennsylvania and the first specialty hospital in the United States to achieve Magnet designation.

PHILADELPHIA (January 23, 2023)—Pedro Torres-Ayuso, PhD, an assistant professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, recently received a grant that will be incorporated into the prestigious Specialized Program of Research Excellence (SPORE) for head and neck cancer held by Fox Chase Cancer Center. 

PHILADELPHIA (January 18, 2023)—Joel Helmke, MSHP, FACHE, chief operating officer of Fox Chase Cancer Center, has been named Vice Chair of the Board of Directors of the Alliance of Dedicated Cancer Centers (ADCC). The trade association represents 10 of the nation’s leading cancer hospitals, including Fox Chase.

PHILADELPHIA (January 17, 2023)—Fox Chase Cancer Center has successfully renewed its accreditation with the National Accreditation Program for Breast Centers (NAPBC), making it the fifth consecutive time Fox Chase has received accreditation.

PHILADELPHIA (January 16, 2023)—Lisa Liu, a third year medical student at the Lewis Katz School of Medicine at Temple University, recently received a 2023 Conquer Cancer Merit Award from the American Society of Clinical Oncology (ASCO) for research that will be presented at an upcoming meeting.

PHILADELPHIA (January 16, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Mitchell Fane, PhD, as an assistant professor in the Cancer Signaling and Microenvironment research program.

PHILADELPHIA (January 16, 2023)— Roland L. Dunbrack Jr., PhD, director of the Molecular Modeling Facility at Fox Chase Cancer Center, recently announced the availability of a new database that contains clusters of homologous protein assembly structures observed in independent structure experiments found in the Protein Data Bank (PDB).